Advertisement

Topics

Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer

2014-11-20 06:14:48 | BioPortfolio

Published on BioPortfolio: 2014-11-20T06:14:48-0500

Clinical Trials [6197 Associated Clinical Trials listed on BioPortfolio]

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

This phase II trial studies how well hypofractionated radiation therapy works in treating patients with stage 0-IIB breast cancer. Hypofractionated radiation therapy delivers higher doses ...

Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation

The primary objective of this study is to determine whether lymphedema rates are decreased in patients requiring regional nodal irradiation (RNI) who receive hypofractionated radiation as ...

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

This randomized phase II trial studies how well hypofractionated radiation therapy works in preventing the return of tumor cells in breast cancer patients following surgery. Hypofractionat...

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

This phase II study is to evaluate the safety of hypofractionated whole breast radiation (HFRT) with simultaneous tumor bed boost(SIB) in women with early breast cancer after breast-conser...

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-Negative Breast Cancer Patients

The purpose of this study is to investigate the difference in late radiation morbidity between hypofractionated and standard fractionated breast irradiation given to women operated with br...

PubMed Articles [8891 Associated PubMed Articles listed on BioPortfolio]

Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series.

We report the incidence of ischaemic cardiac toxicity in a contemporary cohort of patients receiving conventional (CFRT) or hypofractionated (HFRT) radiation after surgery for early breast cancer and ...

Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.

Early-stage breast cancer is among the most prevalent and costly malignancies treated in the American health care system. Adjuvant radiotherapy after lumpectomy represents a substantial portion of bre...

The Dollars and Sense of Hypofractionated Breast Radiation.

Role of Age, Tumor Grade, and Radiation Therapy on Immediate Postmastectomy Breast Reconstruction.

Despite the psychological benefits and oncologic safety of postmastectomy breast reconstruction, most breast cancer patients do not undergo reconstruction. To better understand the patterns of breast ...

Novel Radiotherapy Techniques for Breast Cancer.

During the early decades of radiation therapy for breast cancer, local control of disease was documented consistently but, enigmatically, an anticipated impact on breast cancer survival was not observ...

Medical and Biotech [MESH] Definitions

Abnormal accumulation of lymph in the arm, shoulder and breast area associated with surgical or radiation breast cancer treatments (e.g., MASTECTOMY).

A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.

A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.

More From BioPortfolio on "Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial